StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) stock

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.79+0.09 (+0.61%)

Close on Nov 17, 2026Market cap $12.34BP/E 27.1Yield 0.57%

Dr Reddys Laboratories cash

Cash and short-term investments held at the end of each period.

Dr Reddys Laboratories's cash was ₹15.37B at Mar 31, 2026. For fiscal 2026 it was ₹15.37B, up 4.9% from the year before. The highest annual figure on record is ₹15.37B in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Mar 31, 2026₹15.37B+4.9%
FY2025Mar 31, 2025₹14.65B+106.2%
FY2024Mar 31, 2024₹7.11B+23.0%
FY2023Mar 31, 2023₹5.78B-61.1%
FY2022Mar 31, 2022₹14.85B+0.2%
FY2021Mar 31, 2021₹14.83B+622.3%
FY2020Mar 31, 2020₹2.05B-7.9%
FY2019Mar 31, 2019₹2.23B-15.5%
FY2018Mar 31, 2018₹2.64B-31.8%
FY2017Mar 31, 2017₹3.87B–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ1 2026Mar 31, 2026₹15.37B+3.5%
Q4 FY2025CQ1 2025Mar 31, 2025₹14.65B-1.2%
Q4 FY2024CQ1 2024Mar 31, 2024₹7.11B+246.2%
Q4 FY2023CQ1 2023Mar 31, 2023₹5.78B+159.4%
Q4 FY2022CQ1 2022Mar 31, 2022₹14.85B+463.0%
Q4 FY2021CQ1 2021Mar 31, 2021₹14.83B+283.6%
Q4 FY2020CQ1 2020Mar 31, 2020₹2.05B–
Q4 FY2019CQ1 2019Mar 31, 2019₹2.23B–
Q4 FY2018CQ1 2018Mar 31, 2018₹2.64B–
Q4 FY2017CQ1 2017Mar 31, 2017₹3.87B–

More Dr Reddys Laboratories figures

See a number that looks wrong?